NUMB and breast cancer: The oncogenic function of Notch signaling is associated with high levels of Jagged-1, mainly in prostate and breast cancer, as well as with loss of Numb activity – a negative regulator of Notch-pathway – in 40% of breast cancers and 30% of lung cancers (5, 14, 15).